ICFG Spain / Boltendahl International advises on the Series A+ funding for ZuriMED
Juan was born in Paris from a German mother and a Uruguayan father and grew up between Europe and South America. The impulse of this dual cultural heritage made him travel extensively and choose an international life for himself and his family, today 3 grown children with his German wife. People appreciate working with Juan and enjoy his openness and an approach to business solving problems with pragmatism and concrete solutions… and his interesting sense of humor.
Experience
Juan’s career first years were in banks: NMB bank in Montevideo, Deutsche Bank in Frankfurt and Banco Medefin in Buenos Aires, a bank strongly hit by the crisis known as “1995 Mexican Tequila crisis”. This gave way to Juan launching his own investment boutique company: Boltendahl International Partners was founded in 1996.
After moving to Madrid and launching the European subsidiary of Boltendahl International in 2002, Juan decided to specialize in the Pharma & Healthcare sector, partnering with his old friend Erik Hartmann, an eminent industry expert. The Pharma industry is a vital, stable sector, with large transactions volume and seemed to be a reasonably sound bet for the newly European based company. In time, Boltendahl became more specialized and the partnership with Industry expert Erik, gave way to a longstanding friendship. Boltendahl International Partners is today 26 years old, has six partners, based in different locations (Madrid, New York, Dusseldorf, Montevideo) and changed HQs three times. All partners have international profiles, are intensive travellers and experts in their fields (Pharmaceuticals, Medical Devices, Healthcare, Venture Capital, etc.)
Cross-border M&A is Juan’s playground because there he can apply everything he absorbed through his international childhood, education, languages, and career. Juan approaches the people with kindness and humility, in a respectful and inclusive way, allowing a real partnership with his clients.
Education
Juan studied Economics at the UDELAR Montevideo university and pursued his MBA in IESE, Barcelona, Spain and in Columbia University, New York, USA. The MBA´s “Harvard case method” was a great contrast to the rigorous and tedious textbook learning in the state University of Montevideo.
Life drives and passions
Beyond working, Juan has two present-day passions: sailing with the whole family on French boats in the Balearic Islands, or elsewhere in the Mediterranean, and golfing. Juan used to play tennis, but some injuries brought him to the sport of Golf, that he loves playing together with his family.
ICFG Spain / Boltendahl International advises on the Series A+ funding for ZuriMED
ICFG member based in Spain led by partners Juan Capurro and Charles Depasse advised Swiss-based ZuriMED on their CHF 5 million Series A+ funding round to accelerate market entry in the US. The round was jointly led by a group of Boltendahl related investors, a Swiss VC and another group of US based surgeon investors.
ICFG Spain advised The Beemine Lab with a private placement in the 2nd Seed financing round
The Beemine Lab – 2nd round
The Beemine Lab is a CBD platform using non-psychotropic cannabis extracts, honey, propolis and other bee derivatives.
Boltendahl International / ICFG Spain arranged and closed the 2nd private placement using a Convertible Note in July 2022 after the first one in July 2021, with The Pleasure Fund.
ICFG Spain acts as Financial Adviser to the Investors Syndicate into Spain based The Beemine Lab 0.9m Seed Financing
The Beemine Lab
ICFG Spain (Boltendahl International Partners) organizes a private placement for a syndicate of Spanish based investors in the EUR 0.9m Seed Round for The Beemine Lab.
ICFG Spain acted as Financial Adviser to Ava AG in its Series B financing round
Ava AG
Boltendahl International Partners organizes a private placement in the CHF 30m Series B Round for Ava AG. |
ICFG Spain acted as Financial Advisor to Dermapharm Holding AG (XETRA ETR:DMP) in its acquistion of Spain based Euromed SA
ICFG Spain (Boltendahl International Partners) originated the transaction for Dermapharm and accompained its client during the auction process, helping in the negotiation process until its successful closing. |
ICFG Spain acts as Financial Adviser to the Investors Syndicate into UK based Kokoon Technology Ltd GBP 2m Seed Financing
ICFG Spain (Boltendahl International Partners) organizes a private placement for a syndicate of Spanish based investors in the GBP 2m Seed Round for Kokoon Technologies. |
ICFG Spain acts as Financial Advisor to Villapharma Research in its divestment to Eurofins Scientific (EUFI:PA)
Boltendahl International Partners originated the transaction for Villapharma Research and accompained the deal until its successful closing. |